{'52WeekChange': -0.26926738,
 'SandP52WeekChange': 0.0644362,
 'address1': 'B1, Business Park Terre Bonne',
 'address2': 'Route de Crassier 13',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 8,
 'askSize': 4000,
 'averageDailyVolume10Day': 539412,
 'averageVolume': 1113776,
 'averageVolume10days': 539412,
 'beta': 2.653781,
 'beta3Year': None,
 'bid': 7.45,
 'bidSize': 1000,
 'bookValue': -0.069,
 'category': None,
 'circulatingSupply': None,
 'city': 'Eysins',
 'companyOfficers': [],
 'country': 'Switzerland',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 8.28,
 'dayLow': 7.6,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -10.486,
 'enterpriseToRevenue': 21.32,
 'enterpriseValue': 696213248,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 7.7562857,
 'fiftyTwoWeekHigh': 11.3,
 'fiftyTwoWeekLow': 2.4,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 54080896,
 'forwardEps': -1.04,
 'forwardPE': -7.3846154,
 'fromCurrency': None,
 'fullTimeEmployees': 418,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.02062,
 'heldPercentInstitutions': 0.89816004,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1585612800,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/quotientbd.com',
 'longBusinessSummary': 'Quotient Limited, a commercial-stage diagnostics '
                        'company, develops, manufactures, and sells products '
                        'for the global transfusion diagnostics market in the '
                        'United States, France, Japan, and internationally. '
                        'The company is developing MosaiQ, a proprietary '
                        'technology platform, which provides tests for '
                        'immunohematology and serological disease screening. '
                        'Its conventional reagent products for blood grouping '
                        'include antisera products that are used to identify '
                        'blood group antigens; reagent red blood cells, which '
                        'enable the identification of blood group antibodies; '
                        'whole blood control products for use as daily quality '
                        'assurance tests; and ancillary products that are used '
                        'to support blood grouping. The company is also '
                        'developing microarray-based SARS-CoV-2 antibody test '
                        'for use on the MosaiQ platform for COVID-19. It sells '
                        'its products to hospitals, donor collection agencies, '
                        'independent testing laboratories, original equipment '
                        'manufacturers, and blood banking operation and other '
                        'diagnostics companies. Quotient Limited was founded '
                        'in 2007 and is headquartered in Eysins, Switzerland.',
 'longName': 'Quotient Limited',
 'market': 'us_market',
 'marketCap': 618895872,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_260049407',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -102773000,
 'nextFiscalYearEnd': 1648684800,
 'open': 8.26,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '11 41 22 716 9800',
 'previousClose': 8.27,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 18.95198,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 8.28,
 'regularMarketDayLow': 7.6,
 'regularMarketOpen': 8.26,
 'regularMarketPreviousClose': 8.27,
 'regularMarketPrice': 8.26,
 'regularMarketVolume': 581475,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 80311800,
 'sharesPercentSharesOut': 0.08,
 'sharesShort': 6447307,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 4116656,
 'shortName': 'Quotient Limited',
 'shortPercentOfFloat': 0.105399996,
 'shortRatio': 4.55,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'QTNT',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.435,
 'twoHundredDayAverage': 6.954676,
 'volume': 581475,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.quotientbd.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '1262'}